Search

Your search keyword '"Jean-Philippe Lanoix"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Jean-Philippe Lanoix" Remove constraint Author: "Jean-Philippe Lanoix" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
67 results on '"Jean-Philippe Lanoix"'

Search Results

1. Life threatening rickettsiosis and the role of hemophagocytic lymphohistiocytosis syndrome (HLH): Case report of a 21-year-old woman

2. One Hundred Explicit Definitions of Potentially Inappropriate Prescriptions of Antibiotics in Hospitalized Older Patients: The Results of an Expert Consensus Study

3. Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients

4. Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients

5. Cytomegalovirus-Associated Gianotti-Crosti Syndrome in 28-Year-Old Immunocompetent Patient

6. Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France

8. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis

9. Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

10. Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

11. The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in France

12. Atypical pneumonia clusters

13. Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

15. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

16. No Impact of Corticosteroid Use During the Acute Phase on Persistent Symptoms Post-COVID-19

17. Medical versus surgical treatment in native hip and knee septic arthritis

18. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

19. Author response for 'Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study'

20. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

21. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

22. Comparison of nasopharyngeal and saliva swabs for the detection of RNA SARS-CoV-2 during mass screening (SALICOV study)

23. Holistic Medicine Must Mean Whole: How to Deal with Spirituality

24. Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial

25. Which features of an outpatient treatment for COVID-19 would be most important for pandemic control? A modelling study

26. Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis

27. Trajectories of Hospitalization in COVID-19 Patients: An Observational Study in France

28. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays

29. Characteristics and outcomes of COVID ‐19 in hospitalized patients with and without diabetes

30. Association between renin–angiotensin system inhibitors and COVID-19 complications

31. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection

32. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1

33. Community-acquired granulomatous mastitis superinfected with Mycobacterium bolletii

34. Effect Of Motivational Team On Influenza Vaccination Coverage Among Health Care Workers

35. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

36. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of

37. National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe

38. Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohort

39. Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections

40. Mutations in Rv2983 as a novel determinant of resistance to nitroimidazole drugs in Mycobacterium tuberculosis

41. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis

42. Seasonal flu vaccination: a matter of choice?

43. Syndrome de Fanconi chez un patient de 22 ans d’origine africaine

44. Assessing Urine Human Papillomavirus Polymerase Chain Reaction Testing As a Tool for Screening Anal HPV Infection in HIV-Positive MSM

45. Traitement de la tuberculose ganglionnaire : des recommandations à la pratique

46. High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis

47. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?

48. Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives

49. Juste prescription d’antibiotiques, où en sommes-nous dans notre CHU ?

50. Neisseria meningitidis serogroup B meningitis relapse after five days of cefotaxime treatment: What went wrong?

Catalog

Books, media, physical & digital resources